Latest Global Markets News

Sparc Technologies has secured commercial traction for its graphene additive ecosparc® with major coatings players AkzoNobel and Petro Vietnam Paint, launched a new additive range for electrostatic coatings, and marked six months of continuous operation at its green hydrogen pilot plant.

Encounter Resources has lifted its Aileron niobium resource by over half, hitting 120 million tonnes with robust metallurgical results, while advancing copper-gold drilling in WA and the NT.

Proteomics International Laboratories has streamlined operations, secured a key US patent for its endometriosis test, and inked a three-year exclusive distribution deal with Healius for its Promarker diagnostics in Australia.

Imugene's azer-cel therapy shows a third patient response in the BTKi combination cohort of its Phase 1b trial, while CEO Leslie Chong steps down after nearly 11 years, prompting a leadership search.

BlinkLab has bolstered its war chest with a A$17.5 million placement, secured a foundational US patent valid through 2041, and made significant progress in its FDA autism diagnostic trial and European ADHD study.

VBX Limited has inked a framework agreement with a major Chinese aluminium group to potentially fund and purchase up to 3 million tonnes per annum of bauxite from its Wuudagu project, pending feasibility study outcomes.

Advanced Innergy Holdings (ASX:AIH) has completed its acquisition of Matrix Composites & Engineering (ASX:MCE), significantly expanding its subsea materials manufacturing footprint in the Asia-Pacific region.

CLINUVEL Pharmaceuticals is relocating its corporate headquarters to the United States and reducing its global workforce by up to 20%, realigning its operations to focus solely on the US pharmaceutical market and unlock greater capital access.

Macquarie Group reports a 30% profit increase in FY26 to A$4.85 billion as CEO Shemara Wikramanayake announces retirement, with Greg Ward set to take the helm in November 2026.

AFT Pharmaceuticals has received tentative US FDA approval for its Scomara cream to treat Facial Angiofibromas in Tuberous Sclerosis, but US commercialisation is postponed until 2029 due to orphan drug exclusivity. The approval bolsters regulatory prospects in other key markets where AFT anticipates competitive advantages.

Activeport signs GOIP Globalnet to its Global Edge network, marking the third international carrier deal in a week and reinforcing its strategy for recurring revenue growth.

Boresight Ltd has secured a lease for a new 812 square metre manufacturing hub in Huntsville, Alabama, vastly expanding its US production capacity for aerial target drones amid rising military demand.